Biotricity (OTCMKTS:BTCY) Trading 0.9% Higher

Biotricity, Inc. (OTCMKTS:BTCY)’s stock price shot up 0.9% during mid-day trading on Friday . The company traded as high as $1.32 and last traded at $1.31. 52,961 shares traded hands during mid-day trading, a decline of 27% from the average session volume of 72,895 shares. The stock had previously closed at $1.30.

Biotricity Stock Performance

The stock has a market cap of $12.34 million, a P/E ratio of -0.94 and a beta of 1.46. The business has a 50 day simple moving average of $1.13 and a 200-day simple moving average of $1.27.

Biotricity (OTCMKTS:BTCY) last posted its quarterly earnings results on Tuesday, February 20th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.07. The firm had revenue of $2.97 million for the quarter, compared to the consensus estimate of $3.00 million. On average, sell-side analysts predict that Biotricity, Inc. will post -1.43 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in BTCY. State Street Corp grew its stake in shares of Biotricity by 586.8% during the 1st quarter. State Street Corp now owns 135,295 shares of the company’s stock worth $307,000 after acquiring an additional 115,595 shares during the period. Beacon Pointe Advisors LLC bought a new position in Biotricity in the 1st quarter worth about $77,000. Jane Street Group LLC bought a new position in Biotricity in the 1st quarter worth about $27,000. Virtu Financial LLC bought a new position in Biotricity in the 1st quarter worth about $50,000. Finally, Susquehanna International Group LLP boosted its stake in Biotricity by 53.7% in the 1st quarter. Susquehanna International Group LLP now owns 57,305 shares of the company’s stock worth $27,000 after purchasing an additional 20,024 shares during the period. Institutional investors own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.